RNA Sequencing Market - Forecasts from 2025 to 2030

The RNA sequencing market is projected to grow at a CAGR of 10.49% between 2025 and 2030

RNA sequencing is a known technique that is used to examine the sequences and quantity of RNA in a sample using next-generation sequencing (NGS). The major applications of RNA sequencing are investigating and discovering the transcriptome and the total cellular content of RNAs, including mRNA, rRNA, and tRNA. This allows scientists to understand the overall biology of a cell and assess changes that may indicate disease. Some of the most popular techniques that use RNA sequencing are transcriptional profiling, SNP identification, RNA editing, and differential gene expression analysis. RNA sequencing is considered more valuable as it is not limited to genomic sequences, has a low background signal, and is highly quantifiable.

Market Trends:

• Growing Industry Adoption Fuels RNA Sequencing Market: The widespread uptake of RNA sequencing across various sectors is expected to propel market growth. Compared to traditional methods, RNA sequencing offers superior sensitivity for detecting genes with low or extremely high expression levels and a broader dynamic range (>8000-fold) for identifying transcripts. It provides deeper insights into a cell's transcriptome, enhanced by recent advancements in the RNA-Seq process-from sample preparation and library construction to data analysis. Its proven efficacy, particularly in advancing treatments for diseases like cancer, has driven adoption by leading industries, strengthening healthcare systems and boosting market expansion.
• Government Support Boosts Market Potential: Increased backing from government and private entities is creating a positive outlook for the RNA sequencing market. Many developing nations have ramped up investments in research and development, focusing on RNA sequencing initiatives to deepen understanding of genetics and disease. Government bodies have actively engaged in sequencing programs aimed at improving treatments for cancer and other conditions. This support has spurred the entry of new players and the launch of numerous RNA sequencing projects, fostering industry growth and opening opportunities for established companies.
• North America Sees Rapid Growth: North America is experiencing significant market expansion during the forecast period, driven by the rapid development of structure-based drug design, a growing emphasis on transcriptomics research, and substantial investments in biopharmaceutical R&D. The region's pharmaceutical sector is seeing robust growth, largely due to heightened spending on research and drug development, which serves as a key driver for market leaders' revenue gains.

Some of the major players covered in this report Roche Holding AG, Agilent Technologies, Illumina, Inc., Thermo Fisher Scientific, Macrogen, Inc., Beijing Genomics Institute, Qiagen, DNASTAR, GATC Biotech AG, Pacific Biosciences of California, Inc., among others.

Key Benefits of this Report:

• Insightful Analysis: Gain detailed market insights covering major as well as emerging geographical regions, focusing on customer segments, government policies and socio-economic factors, consumer preferences, industry verticals, and other sub-segments.
• Competitive Landscape: Understand the strategic maneuvers employed by key players globally to understand possible market penetration with the correct strategy.
• Market Drivers & Future Trends: Explore the dynamic factors and pivotal market trends and how they will shape future market developments.
• Actionable Recommendations: Utilize the insights to exercise strategic decisions to uncover new business streams and revenues in a dynamic environment.
• Caters to a Wide Audience: Beneficial and cost-effective for startups, research institutions, consultants, SMEs, and large enterprises.

What do businesses use our reports for?

Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive Intelligence

Report Coverage:

• Historical data from 2022 to 2024 & forecast data from 2025 to 2030
• Growth Opportunities, Challenges, Supply Chain Outlook, Regulatory Framework, and Trend Analysis
• Competitive Positioning, Strategies, and Market Share Analysis
• Revenue Growth and Forecast Assessment of segments and regions including countries
• Company Profiling (Strategies, Products, Financial Information, and Key Developments among others)

RNA Sequencing Market Segmentation:

By Technology

• Ion Semiconductor Sequencing
• Single-Molecule Real-Time (SMRT) Sequencing
• Nanopore Sequencing
• Sequencing By Synthesis (SBS)

By Applications

• Small RNA Sequencing
• Expression Profiling Analysis
• De Novo Transcriptome Assembly
• Variant Calling and Transcriptome Epigenetics
• RNA Editing

By End-User

• Research Centers
• Biotechnology Labs
• Healthcare Centers
• Others

By Geography

• North America
• United States
• Canada
• Mexico
• South America
• Brazil
• Argentina
• Others
• Europe
• Germany
• France
• Spain
• United Kingdom
• Others
• Middle East and Africa
• UAE
• Saudi Arabia
• Others
• Asia Pacific
• China
• Japan
• India
• South Korea
• Thailand
• Indonesia
• Taiwan
• Others